Search Results - "Philogene, Mary"

Complete Immunosuppression Withdrawal and Subsequent Allograft Function Among Pediatric Recipients of Parental Living Donor Liver Transplants by Feng, Sandy, Ekong, Udeme D, Lobritto, Steven J, Demetris, Anthony J, Roberts, John P, Rosenthal, Philip, Alonso, Estella M, Philogene, Mary C, Ikle, David, Poole, Katharine M, Bridges, Nancy D, Turka, Laurence A, Tchao, Nadia K

“…CONTEXT Although life-saving, liver transplantation burdens children with lifelong immunosuppression and substantial potential for morbidity and mortality…”
Get full text

Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study by Jang, Moon Kyoo, Tunc, Ilker, Berry, Gerald J., Marboe, Charles, Kong, Hyesik, Keller, Michael B., Shah, Pali D., Timofte, Irina, Brown, Anne W., Ponor, Ileana L., Mutebi, Cedric, Philogene, Mary C., Yu, Kai, Iacono, Aldo, Orens, Jonathan B., Nathan, Steven D., Agbor-Enoh, Sean

“…Acute rejection, which includes antibody-mediated rejection and acute cellular rejection, is a risk factor for lung allograft loss. Lung transplant patients…”
Get full text

Histopathologic Changes In Anti-Angiotensin Ii Type 1 Receptor Antibody-Positive Kidney Transplant Recipients With Acute Rejection And No Donor Specific Hla Antibodies by Ann Lim, Mary, Palmer, Matthew, Trofe-Clark, Jennifer, Bloom, Roy, Jackson, Annette, Carmelle Philogene, Mary, Kamoun, Malek

“…Abstract Objective To determine the association of antibodies against angiotensin II type 1 receptor (AT1R Ab) and histopathologic changes seen in patients…”
Get full text

Utilizing proficiency testing survey data to create advanced educational content: the virtual crossmatch challenge model by Hod-Dvorai, Reut, Philogene, Mary Carmelle, Timofeeva, Olga, Gimferrer, Idoia, Dunckley, Heather, Greenshields, Anna, Jindra, Peter

“…Proficiency testing (PT) surveys include data from laboratories across the world and are ideal for creating advanced educational content, beyond just consensus…”
Get full text

Differential Effect of Bortezomib on HLA Class I and Class II Antibody by Philogene, Mary Carmelle, Sikorski, Paul, Montgomery, Robert A, Leffell, Mary S, Zachary, Andrea A

“…BACKGROUNDBortezomib has been used to reduce HLA antibody in patients either before transplantation or as treatment for antibody-mediated rejection (AMR)…”
Get full text

Distinct Caenorhabditis elegans HLH-8/twist-containing dimers function in the mesoderm by Philogene, Mary C., Meyers Small, Stephany G., Wang, Peng, Corsi, Ann K.

“…Background: The Caenorhabditis elegans basic helix‐loop‐helix (bHLH) factor HLH‐8, the single Twist ortholog in the nematode genome, plays important roles in…”
Get full text

Histocompatibility and hematopoietic stem cell transplantation by Philogene, Mary Carmelle

Get full text

Successful A2 to B Deceased Donor Kidney Transplant after Desensitization for High-Strength Non-HLA Antibody Made Possible by Utilizing a Hepatitis C Positive Donor by Lonze, Bonnie E., Philogene, Mary Carmelle, Friedlander, Rex, Tatapudi, Vasishta S., Lawson, Nikki, Ali, Nicole M., Karpel, H. Charli, Montgomery, Robert A.

“…Desensitization using plasma exchange can remove harmful antibodies prior to transplantation and mitigate risks for hyperacute and severe early acute…”
Get full text

Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity by Philogene, Mary Carmelle, Johnson, Tory, Vaught, Arthur Jason, Zakaria, Sammy, Fedarko, Neal

“…Antibodies against two G-protein coupled receptors (GPCRs), angiotensin II type 1 receptor (AT1R) and endothelin A receptor (ETAR) are among a growing number…”
Get full text

Current donor selection strategies for allogeneic hematopoietic cell transplantation by Timofeeva, Olga A., Philogene, Mary Carmelle, Zhang, Qiuheng Jennifer

Get full text

Successful A2 to O Simultaneous Liver and Kidney Transplantation in the Setting of Pre-operative Positive HLA Crossmatch: A Case Report by Vigneshwar, Mythili, Sambommatsu, Yuzuru, Gupta, Gaurav, Philogene, Mary Carmelle, Bruno, David A.

“…•The initial negative HLA antibody screening for the simultaneous liver and kidney transplantation (SLKT) recipient turned positive (calculated panel reactive…”
Get full text

Pathogenic consequences of Neisseria gonorrhoeae pilin glycan variation by Ghosh, Salil K., Zhao, Jie, Philogene, Mary C., Alzaharani, Abdulrahaman, Rane, Supriya, Banerjee, Asesh

“…A Neisseria gonorrhoeae (gonococcus, GC) pilin glycosylation gene, pgtA, can either possess or lack phase-variation ability. Many GC, particularly the…”
Get full text

Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies by Philogene, Mary Carmelle, Bagnasco, Serena, Kraus, Edward S., Montgomery, Robert A., Dragun, Duska, Leffell, Mary S., Zachary, Andrea A., Jackson, Annette M.

“…BACKGROUNDThis is a cross-sectional study designed to evaluate the histologic characteristics of graft injury in the presence of anti-angiotensin II type 1…”
Get full text

Presentation and Outcomes of Antibody-Mediated Rejection Associated With Angiotensin II Receptor 1 Antibodies Among Kidney Transplant Recipients by Abuzeineh, Mohammad, Kyeso, Yousuf, Philogene, Mary Carmelle, Alachkar, Nada, Alasfar, Sami

“…It remains challenging to manage antibody-mediated rejection (ABMR) associated with angiotensin II type 1 receptor antibodies (AT1R-Abs) in kidney transplant…”
Get full text

Management of human leukocyte antigen-mediated platelet transfusion refractoriness: Brief synopsis and recent literature review by Panch, Sandhya R, Vassallo, Ralph R, Adams, Sharon, Borge, Dayand P, Gammon, Richard, Gandhi, Manish J, Philogene, Mary, Sullivan, Harold C, Wu, YanYun, Kopko, Patricia

Get full text

Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis by Philogene, Mary Carmelle, Amin, Anita, Zhou, Sheng, Charnaya, Olga, Vega, Renato, Desai, Niraj, Neu, Alicia M., Pruette, Cozumel S.

“…HLA eplet mismatch load has been suggested as an improvement to HLA antigen mismatch determination for organ selection. Given that eplet mismatches are…”
Get full text

P064 Serum treatment in a flow crossmatch by Lucas, Donna, Jackson, Annette, Philogene, Mary Carmelle

“…Aim Autoantibodies present in patient sera may cause a positive flow cytometric crossmatch that is not clinically relevant. Previous studies have shown that…”
Get full text

Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of CLAD or Death by Keller, Michael, Yang, Song, Ponor, Lucia, Bon, Ann, Cochrane, Adam, Philogene, Mary, Bush, Errol, Shah, Pali, Mathew, Joby, Brown, Anne W, Kong, Hyesik, Charya, Ananth, Luikart, Helen, Nathan, Steven D, Khush, Kiran K, Jang, Moon, Agbor-Enoh, Sean

“…The development of donor-specific antibodies after lung transplantation is associated with downstream acute cellular rejection (ACR), antibody-mediated…”
Get full text

Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death by Keller, Michael, Yang, Song, Ponor, Lucia, Bon, Ann, Cochrane, Adam, Philogene, Mary, Bush, Errol, Shah, Pali, Mathew, Joby, Brown, Anne W., Kong, Hyesik, Charya, Ananth, Luikart, Helen, Nathan, Steven D., Khush, Kiran K., Jang, Moon, Agbor-Enoh, Sean

“…The development of donor-specific antibodies after lung transplantation is associated with downstream acute cellular rejection, antibody-mediated rejection…”
Get full text

P247 Evaluation of ABHI approved in-house continuing education program by Chesterton, Kevin, Jackson, Annette M., Bettinotti, Maria, Philogene, Mary C.

“…To evaluate the efficacy of continuing education credits (CEC) offered to histocompatibility technical staff. In order to increase continuing education…”
Get full text